About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6556 record(s)
Req # A-2023-001348
All records related to the licensing of Natural Health Product Natural Product Number (NPN) 80097297 pursuant to the Natural Health Products Regulation under the Food and Drugs Act. All relevant documents in the reporting, licensing request, and approval documents and or records.Organization: Health Canada
May 2024
Req # A-2023-001395
All information in the submission and review of Natural Product Number (NPN) 80087738, brand name: Apple Cider Vinegar.Organization: Health Canada
May 2024
Req # A-2023-001433
All records between the federal government and the province of Albert relating to gender affirming care and puberty blockers for youth from August 10, 2023, to February 10, 2024.Organization: Health Canada
May 2024
Req # A-2023-001480
According to the Health Canada Generic Submissions Under Review (GSUR) List, Health Canada is currently reviewing an Abbreviated Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient degarelix acetate. If the Degarelix ANDS has received a Screening Acceptance Letter, provide the month and year that the notice was issued; provide a copy of the correspondence.Organization: Health Canada
May 2024
Req # A-2023-001486
Correspondence relating to any Abbreviated New Drug Submission (ANDS) accepted into review as of February 22, 2024 where the medicinal ingredient is degarelix acetate and the correspondence mentions “bio-waiver”.Organization: Health Canada
May 2024
Req # A-2023-001487
Records containing information regarding the evidence of clinical effectiveness of the Degarelix Abbreviated New Drug Submission (ANDS) for the purpose and under the conditions of use recommended, as described in the Food and Drug Regulations.Organization: Health Canada
May 2024
Req # A-2023-001506
From February 28, 2023-February 29, 2024, final versions of all briefing notes / memos/ anticipated media Questions & Answers regarding Kenneth Law and/or Sodium nitrite and it’s use as a suicide substance that were sent to/received by: Minister of Health, Minister of Mental Health, Deputy Minister and Associate Deputy Minister of Health, Assistant Deputy Minister for the Communications and Public Affairs Branch.Organization: Health Canada
May 2024
Req # A-2023-001523
In respect of the First Liraglutide Abbreviated New Drug Submission (ANDS), please provide the name of the company who submitted this ANDS.Organization: Health Canada
May 2024
Req # A-2023-001527
As of December 15, 2023, there are now two liraglutide submissions which appear on the Generic Submissions Under Review (GSUR) List. Provide the name of the company who submitted the Abbreviated New Drug Submission (ANDS); and the year and month in which the ANDS was accepted for review.Organization: Health Canada
May 2024
Req # A-2023-001536
As part of its application to Health Canada for authorization to sell the COVID-19 lateral flow device with the Interim Order (IO) authorization Identification 327866, the manufacturer sent the federal government about 200 sample tests. Provide the report that the Health Canada team led by the Director General received from the National Microbiology Laboratory on the test's accuracy and considered as they evaluated the application, approving it on October 20, 2021.Organization: Health Canada
May 2024